Pharmaceutical preparations company · DE · FY ends Dec · -72.84% margin · -$88M FCF
The business is unprofitable at the operating level (-72.84% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 3024.4% YoY with margins expanding 4598.2pp.
Negative free cash flow of -$73M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (FY)
$219M
▲ +3024.4% YoY
Net Income (TTM)
-$140M
▲ +58.6% YoY
Op. Margin
-72.84%
▲ +4598.2pp YoY
ROIC
-14.06%
▲ +18.5pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$88M
▲ +70.8% YoY
Op. Cash Flow (TTM)
-$86M
▲ +71.3% YoY
Net Debt
-$643M
Net Cash Position
Cash & Equiv.
$671M
5Y CAGR: +62.1%
Continue Research